364 related articles for article (PubMed ID: 25100651)
1. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
[TBL] [Abstract][Full Text] [Related]
2. Can LENT Prognostic score (LDH, ECOG performance score, blood neutrophil/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?
Gayaf M; Anar C; Canbaz M; Doğan Bİ; Erbaycu AE; Güldaval F
Tuberk Toraks; 2021 Jun; 69(2):133-143. PubMed ID: 34256503
[TBL] [Abstract][Full Text] [Related]
3. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
Abisheganaden J; Verma A; Dagaonkar RS; Light RW
Respiration; 2018; 96(4):308-313. PubMed ID: 29945142
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prognostication scores and proposal for refinement in malignant pleural effusion in Asians.
Wong C; Wing-Cheuk Wong R; Kit-Ying So L; Yin-Chun Yam L
Respir Med; 2021; 189():106650. PubMed ID: 34688123
[TBL] [Abstract][Full Text] [Related]
5. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion.
Li T; Tian P; Huang Q; Zeng H; Wei Q; Li Y
Clin Respir J; 2023 Nov; 17(11):1158-1168. PubMed ID: 37723659
[TBL] [Abstract][Full Text] [Related]
7. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
[TBL] [Abstract][Full Text] [Related]
9. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
Lee YS; Nam HS; Lim JH; Kim JS; Moon Y; Cho JH; Ryu JS; Kwak SM; Lee HL
BMC Cancer; 2017 Aug; 17(1):557. PubMed ID: 28830378
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.
Psallidas I; Kanellakis NI; Gerry S; Thézénas ML; Charles PD; Samsonova A; Schiller HB; Fischer R; Asciak R; Hallifax RJ; Mercer R; Dobson M; Dong T; Pavord ID; Collins GS; Kessler BM; Pass HI; Maskell N; Stathopoulos GT; Rahman NM
Lancet Oncol; 2018 Jul; 19(7):930-939. PubMed ID: 29908990
[TBL] [Abstract][Full Text] [Related]
12. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
13. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.
Bibby AC; Clive AO; Slade GC; Morley AJ; Fallon J; Psallidas I; Pepperell JCT; Slade MG; Stanton AE; Rahman NM; Maskell NA
Chest; 2015 Jul; 148(1):235-241. PubMed ID: 25429399
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
Takeuchi E; Okano Y; Machida H; Atagi K; Kondou Y; Kadota N; Hatakeyama N; Naruse K; Shinohara T
Cancer Immunol Immunother; 2022 Feb; 71(2):365-372. PubMed ID: 34170380
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors of Malignant Pleural Effusion among Palliative Care Outpatients: A Retrospective Study.
Jeba J; Cherian RM; Thangakunam B; George R; Visalakshi J
Indian J Palliat Care; 2018; 24(2):184-188. PubMed ID: 29736123
[TBL] [Abstract][Full Text] [Related]
16. Malignant pleural effusion survival prognostication in an Asian population.
Quek JC; Tan QL; Allen JC; Anantham D
Respirology; 2020 Dec; 25(12):1283-1291. PubMed ID: 32390227
[TBL] [Abstract][Full Text] [Related]
17. Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2022 Jan; 23(1):25-31. PubMed ID: 35092368
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility of the LENT score in patients with malignant pleural mesothelioma.
Söyler Y; Kavurgacı S; Gürel Akan E; Yılmaz Ü
Tuberk Toraks; 2022 Dec; 70(4):341-348. PubMed ID: 36537091
[TBL] [Abstract][Full Text] [Related]
19. Validating LENT score in malignant pleural effusion.
Alawneh A; Farsakh FA; Smadi M; Samrah S
Future Sci OA; 2024; 10(1):FSO958. PubMed ID: 38817378
[No Abstract] [Full Text] [Related]
20. Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?
Abrao FC; Peixoto RD; de Abreu IR; Janini MC; Viana GG; de Oliveira MC; Younes RN
J Surg Oncol; 2016 Apr; 113(5):570-4. PubMed ID: 26751412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
